Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • E-pharmacy startup...

    E-pharmacy startup Myra Manages funds for expansion in new markets

    Written by Ruby Khatun Khatun Published On 2017-04-27T10:22:35+05:30  |  Updated On 18 Aug 2021 2:18 PM IST
    Bengaluru: Myra Medicine, a Bengaluru based online pharmacy, promising doorstep delivery of medicines in 30 minutes with 15 per cent discount has managed to rope in Matrix Partners and Times Internet, a part of the Times group to invest Together around $7-8 million in their project, it is learnt.

    The idea of Myra Medicines stemmed from problem faced by residents of Bengaluru due to inaccessibility of medicines at a time of need. In order to solve this problem and to shorten delivery time using technology and data science Team of Myra Medicines took a decision to launch Myra in April 2015.

    Myra Medicines works with 40 distributors across the country and it verifies all licences before dealing with the distributors. One can place order through myramed app, SMS or call. Once the order gets forwarded to their closet dispatch centre, it is then checked and reaches the customer in 30 minutes. At present the company is clocking about 1,000 orders per day and plans to grow by three to four times in the next nine months. The company employs, directly and indirectly, about 300 people and plans to take that up to 900 by end of the year.

    Myra runs on a full-stack model wherein it has a drug license and registered pharmacists who validate the authenticity of each prescription before dispensing medicines. With the latest funds in, Myra is planning to enter new metro cities in addition to Bengaluru where it had been operating since inception. While speaking to TOI Faizan Aziz, founder and CEO, Myra said "We are looking to start operations in Mumbai, Delhi, Hyderbad, Pune while we deepen our network within Bengaluru." In India, where pharmacy retail market has been largely dominated by physical stores growing adoption of e-commerce platforms is likely to modify purchasing patterns of medicines.

    Tarun Davda, MD at Matrix Partners, said the current customer experience is broken at the fundamental level despite advances in technology for the $15 billion Indian pharma market. "Myra takes a high frequency use case and makes it super easy for users to access a pharmacy digitally," said Miten Sampat, VP-corporate development, Times Internet

    As many as 140 startups are currently operating in the online pharmacy market, with 18 of them having managed to raise funds. Around $110 million has been poured into these startups with the likes of NetMeds, PharmEasy and 1mg emerging as the most well funded companies in the sector, data from Tracxn pointed out.
    1mg7-8 million dollarFaizan AzizInvestmentMatrix PartnersMiten SampatMyra MedicinesmyramedNetmedsOnline PharmacyPharmEasyTarun DavdaTimes Internet
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok